Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H RAS mutations in haematologically normal individuals.

C Taylor1, J Larghero, C Thomas

  • 1Hematology Department, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK.

The Hematology Journal : the Official Journal of the European Haematology Association
|March 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction for Cassinat et al., "New Role for Granulocyte Colony-Stimulating Factor-Induced Extracellular Signal-Regulated Kinase 1/2 in Histone Modification and Retinoic Acid Receptor α Recruitment to Gene Promoters: Relevance to Acute Promyelocytic Leukemia Cell Differentiation".

Molecular and cellular biology·2017
Same author

Preclinical modeling of myelodysplastic syndromes.

Leukemia·2017
Same author

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.

Leukemia·2016
Same author

A lesson from persistently elevated aspartate transaminases (AST) in a patient with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.

Blood cancer journal·2015
Same author

Importance of reference gene selection for articular cartilage mechanobiology studies.

Osteoarthritis and cartilage·2015
Same journal

Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment.

The hematology journal : the official journal of the European Haematology Association·2005
Same journal

Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats.

The hematology journal : the official journal of the European Haematology Association·2005
Same journal

The effect of iron deficiency anemia on the function of the immune system.

The hematology journal : the official journal of the European Haematology Association·2005
Same journal

Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.

The hematology journal : the official journal of the European Haematology Association·2005
Same journal

Malignant diseases of hematopoietic and lymphoid tissues in Chernobyl clean-up workers.

The hematology journal : the official journal of the European Haematology Association·2005
Same journal

Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.

The hematology journal : the official journal of the European Haematology Association·2005
See all related articles

RAS mutations are linked to blood cancers. This study screened 115 normal individuals for RAS mutations, finding two cases of H RAS mutations, with both individuals remaining healthy.

Area of Science:

  • Oncology
  • Genetics
  • Hematology

Background:

  • RAS gene mutations are implicated in hematological malignancies.
  • The baseline prevalence of RAS mutations in healthy individuals is largely unknown.
  • Understanding RAS mutation frequency in normal populations is crucial for cancer research.

Purpose of the Study:

  • To determine the frequency of RAS mutations in a cohort of hematologically normal individuals.
  • To establish a baseline for RAS mutation prevalence in the general population.
  • To investigate the presence of RAS mutations outside of active cancer.

Main Methods:

  • Screening of DNA from 115 healthy individuals for point mutations in N, K, and H RAS genes.
  • Targeted analysis at critical amino acid positions (12, 13, and 61).

Related Experiment Videos

  • Utilized polymerase chain reaction, oligonucleotide hybridization, cloning, and sequencing for mutation detection and confirmation.

    • Main Results:

    • Point mutations in the H RAS gene were detected in two out of 115 individuals.
    • Both identified mutations involved an amino acid substitution at position 12.
    • Individuals with detectable H RAS mutations exhibited no signs of hematological abnormalities.

    Conclusions:

    • RAS mutations can be present in individuals without hematological malignancies.
    • The study establishes a low baseline frequency of detectable RAS mutations in a normal population.
    • Further research is warranted to understand the long-term implications of these findings.